Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient-derived cell line, xenograft and organoid models in lung cancer therapy
Ku-Geng Huo, Elisa D’Arcangelo, Ming‐Sound Tsao
Translational Lung Cancer Research (2020) Vol. 9, Iss. 5, pp. 2214-2232
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Patient-derived xenograft (PDX) models, applications and challenges in cancer research
Shahrokh Abdolahi, Zeinab Ghazvinian, Samad Muhammadnejad, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 166
The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
Shimin Xie, Zhengguo Wu, Yi Qi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111450-111450
Open Access | Times Cited: 105
Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy
Masashi Mikubo, Yoshiaki Inoue, Geoffrey Liu, et al.
Journal of Thoracic Oncology (2021) Vol. 16, Iss. 11, pp. 1798-1809
Open Access | Times Cited: 101
Patient-derived organoids in translational oncology and drug screening
Ruixin Yang, Yingyan Yu
Cancer Letters (2023) Vol. 562, pp. 216180-216180
Open Access | Times Cited: 54
Functional precision oncology using patient-derived assays: bridging genotype and phenotype
Allard W. J. van Renterghem, Joris van de Haar, Emile E. Voest
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 5, pp. 305-317
Closed Access | Times Cited: 53
A Beginner’s Guide to Cell Culture: Practical Advice for Preventing Needless Problems
Sabine Weiskirchen, Sarah K. Schröder, Eva Miriam Buhl, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 682-682
Open Access | Times Cited: 42
Role of Patient-Derived Models of Cancer in Translational Oncology
K. Idrisova, Hans‐Uwe Simon, Marina Gomzikova
Cancers (2022) Vol. 15, Iss. 1, pp. 139-139
Open Access | Times Cited: 49
Cancer‐associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications
Kit Yee Wong, Alvin Ho‐Kwan Cheung, Bonan Chen, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 8, pp. 1195-1215
Open Access | Times Cited: 45
Preclinical models in head and neck squamous cell carcinoma
Patrícia Chaves, Marı́a J. Garrido, Javier Oliver, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 10, pp. 1819-1827
Open Access | Times Cited: 21
Inhalable nanomedicine for lung cancer treatment
Shuiying Zhang, Rui Li, Tong Jiang, et al.
Smart Materials in Medicine (2024) Vol. 5, Iss. 2, pp. 261-280
Open Access | Times Cited: 6
Organoid: a powerful tool to study lung regeneration and disease
Tiantian Lu, Yiyuan Cao, Peng Zhao, et al.
Cell Regeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids
Melissa C. Skala, Dustin A. Deming, Jeremy D. Kratz
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 157-177
Open Access | Times Cited: 31
Expression of Endogenous Angiotensin-Converting Enzyme 2 in Human Induced Pluripotent Stem Cell-Derived Retinal Organoids
Henkie Isahwan Ahmad Mulyadi Lai, Shih‐Jie Chou, Yueh Chien, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1320-1320
Open Access | Times Cited: 31
Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications
Xiao Zeng, Qiong Ma, Xueke Li, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 12
A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments
Fenneke Zwierenga, Bianca van Veggel, Anke van den Berg, et al.
Cancer Treatment Reviews (2023) Vol. 120, pp. 102628-102628
Open Access | Times Cited: 11
Tumor Organoids: The Era of Personalized Medicine
Natalia V Rassomakhina, A. Yu. Ryazanova, Astemir R. Likhov, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. S1, pp. S127-S147
Closed Access | Times Cited: 3
Progress on the study of the anticancer effects of artesunate (Review)
Xiulan Yang, Yudong Zheng, Lian Liu, et al.
Oncology Letters (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 30
Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030
Yuan Fang, Zhen Li, Hui Chen, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 7, pp. 3209-3218
Closed Access | Times Cited: 18
Lung Cancer Organoids: The Rough Path to Personalized Medicine
Rachele Rossi, Maria Laura De Angelis, Eljona Xhelili, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3703-3703
Open Access | Times Cited: 18
Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
Xiao-Hai Song, Lan Yang, Xiuli Zheng, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 10
Development of lung tissue models and their applications
Nalinrat Petpiroon, Woranan Netkueakul, Kanokwan Sukrak, et al.
Life Sciences (2023) Vol. 334, pp. 122208-122208
Closed Access | Times Cited: 10
Hydrogels to engineer tumor microenvironmentsin vitro
Kanishka Fernando, Leng Gek Kwang, Joanne Tze Chin Lim, et al.
Biomaterials Science (2021) Vol. 9, Iss. 7, pp. 2362-2383
Open Access | Times Cited: 25
From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas
Xueyuan Sun, Şevin Turcan
Cells (2021) Vol. 10, Iss. 5, pp. 1225-1225
Open Access | Times Cited: 24
Advanced Nanoparticle-Based Drug Delivery Systems and Their Cellular Evaluation for Non-Small Cell Lung Cancer Treatment
Noratiqah Mohtar, Thaigarajan Parumasivam, Amirah Mohd Gazzali, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3539-3539
Open Access | Times Cited: 22
Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress
Laura Martinez‐Ruiz, Javier Florido, César Rodríguez-Santana, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115518-115518
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top